Michele Nanna is a Cardiology physician affiliated with Albert Einstein College of Medicine. OpenAlex indexes 96 publications with 1,009 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1461 Astor Ave
Bronx, NY 104695812
Telephone
718-655-1060Registry record last updated 18 Dec 2018.
Industry payments
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20253 payments
- Amgen Inc.Program year20252 payments
- Novartis Pharmaceuticals CorporationProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
88.9%Beta blocker20.6%Labetalol Hcl36%Metoprolol Succinate35%Carvedilol21%Nebivolol Hcl7%Part D<11 patientsCalcium channel blocker17.3%Amlodipine Besylate78%Diltiazem 24hr Er (Cd)11%Amlodipine-Valsartan6%Amlodipine Besylate-Benazepril5%Part D<11 patients+ 11 more classes in this area
Blood & clotting
7.4%Factor Xa inhibitor5.6%Eliquis85%Xarelto15%Part D<11 patientsP2Y12 inhibitor1.8%Clopidogrel100%Part D<11 patientsMetabolism & gastrointestinal
3.7%SGLT2 inhibitor3.7%Jardiance77%Farxiga23%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 26-A-17626-ACC GLOBAL TRENDS IN MEASURING LIPOPROTEIN(A) AND C-REACTIVE PROTEIN IN PATIENTS WITH ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
Journal of the American College of Cardiology
2026 - Global trends in lipoprotein(a) and high-sensitivity c-reactive protein testing in patients with established atherosclerotic cardiovascular disease
American Journal of Preventive Cardiology
2026 - Ultrasound-Based assessment of systemic congestion in pulmonary hypertension
Current Opinion in Cardiology
2025 - Venous Excess Ultrasound in Decompensated Heart Failure: Prognostic Strength Signals Readiness for Therapeutic Evaluation
Journal of the American Society of Echocardiography
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Lipton, MD
Albert Einstein College of Medicine
Marina Konopleva, MD, PhD
Albert Einstein College of Medicine
Solomon Moshe, MD
Albert Einstein College of Medicine
Shlomo Shinnar, MD, PhD
Albert Einstein College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”